Executive Vice President and Chief Operating Officer · Emergent BioSolutions Inc. (EBS)

Adam Havey

A named executive officer of Emergent BioSolutions in every fiscal year CompBrief holds from FY2016 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$2,010,487

Salary $557,966Stock awards $842,228

FY2022: $3,621,626

4th of 7 named executive officers at Emergent BioSolutions by FY2023 total.

7 named officers on file for Emergent BioSolutions, FY2023

Adam Havey’s pay file — $29

  • 8 fiscal years of pay, line by line
  • 15 equity grants, each cited to its filing
  • EBS’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Emergent BioSolutions’s whole pay program stands against its peers

  • Emergent BioSolutions’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on EBS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 11, 2024 (DEF 14A).

Free

Get Adam Havey’s full pay file as a PDF — free

More than this page: up to 10 years of Adam’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Adam Havey compensation by year

Emergent BioSolutions Summary Compensation Table · all 8 fiscal years held
In US dollars, as Emergent BioSolutions reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023
Salary$431,019$448,842$480,728$484,120$546,507$574,270$574,846$557,966
Bonus$0$0$0$0$0$0$0$0
Stock awards$262,487$262,499$499,974$619,984$700,047$700,053$2,075,000$842,228
Option awards$136,269$173,794$359,784$436,154$475,413$549,630$791,185$313,250
Non-equity incentive$149,611$264,177$310,212$279,579$445,204$261,405$172,770$0
Pension and deferred compensation$0$0$0$0$0$0$0$0
All other$8,683$8,983$8,383$25,530$8,357$7,425$7,825$297,042
Total$988,069$1,158,295$1,659,081$1,845,367$2,175,528$2,092,783$3,621,626$2,010,487

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Emergent BioSolutions Inc. DEF 14A filed April 11, 2024, accession 0001193125-24-093400, and prior-year filings.

How this page was built: the Emergent BioSolutions Inc. filed document, accession 0001193125-24-093400. Every figure is read from that document and cited to the page and table it appears in. Filed April 11, 2024.

$988K
$1.2M
$1.7M
$1.8M
$2.2M
$2.1M
$3.6M
$2.0M
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
SalaryNon-equity incentiveStock awardsOption awardsAll other

Emergent BioSolutions’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Robert KramerFormer President, Chief Executive Officer and Director$5,103,858
Richard LindahlExecutive Vice President, Chief Financial Officer and Treasurer$2,178,980
Jennifer FoxExecutive Vice President, External Affairs, General Counsel and Corporate Secretary$2,131,320
Adam Havey · this pageExecutive Vice President and Chief Operating Officer$2,010,487
Coleen GlessnerExecutive Vice President, Quality and Ethics and Compliance$1,681,538
Paul WilliamsSenior Vice President, Products Business$1,063,639
Haywood MillerInterim Chief Executive Officer$766,667

The full Emergent BioSolutions compensation record

free company brief

This page is one person within Emergent BioSolutions's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Emergent BioSolutions proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Emergent BioSolutions's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Adam Havey's compensation dossier · One-time report. No refunds.